# Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/assessing-user-fees-under-the-generic-drug-user-fee-amendments-of-2017-guidance-for-industry/15016857-1152-47bd-87a5-412d726e1dfc

> FDA guidance document: Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry. Issue date: October 30, 2017. Get complete insights and analysis.

---

## Details

- Title: Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry
- Communication Type: Guidance Document
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Issue Date: 2017-10-30
- Docket Number: FDA-2012-D-0880

## Related Documents

- [Study and Evaluation of Sex Differences in the Clinical Evaluation of Drugs:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/study-and-evaluation-of-sex-differences-in-the-clinical-evaluation-of-drugs-guidance-for-industry/3a0ffb0a-7a37-4bc1-87ac-ca6b3fb05058)
- [Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/limiting-the-use-of-certain-phthalates-as-excipients-in-cder-regulated-products-guidance-for-industry/3781a274-d4b8-4b5c-b800-79fcdaac4674)
- [ICH Q3C Maintenance Procedures for the Guidance for Industry Q3C Impurities: Residual Solvents](https://www.keypedia.com/guidances/guidance-document/ich-q3c-maintenance-procedures-for-the-guidance-for-industry-q3c-impurities-residual-solvents/8194e605-7d54-41b1-8882-4d94c2a7a60a)